Schroeder Quoted on Changes to NLRB Rulings Based on President Trump’s Nominees
12 July 2017
Partner Don Schroeder was quoted in an SHRM.org article, “NLRB Nominees Expected to Undo Obama-Era Rulings,” covering potential changes to the NLRB rulings from President Trump’s nominees on joint employers, micro-unions and NLRB enforcement.
Among many comments throughout the article, Schroeder specifically explained that the NLRB under Republican leadership would not “continue to dip their toes into the area of employee handbooks and confidentiality provisions.”
Among many comments throughout the article, Schroeder specifically explained that the NLRB under Republican leadership would not “continue to dip their toes into the area of employee handbooks and confidentiality provisions.”
People
Related News
25 July 2024
In the News
Donald Schroeder on Groff – ‘Supreme Court decision is inviting a more fact-based analysis’
Foley & Lardner LLP partner Donald Schroeder assessed the impact of the U.S. Supreme Court’s 2023 decision in a religious accommodation case as it returns to the district court in the Law360 article, “A Year After High Court Spotlight, Groff Case Still A Bellwether.”
24 July 2024
In the News
Louis Lehot Featured in Q&A on How Startups Can Prepare for IPO
Foley & Lardner LLP partner Louis Lehot features in the Q&A, "How startups can get in top shape for an IPO, according to Silicon Valley lawyer Louis Lehot," part of Business Insider's Road to IPO' series.
24 July 2024
In the News
Courtenay Brinckerhoff on Patent Cap in Drug Pricing – ‘Hard to predict if this will make a difference’
Foley & Lardner LLP partner Courtenay Brinckerhoff discussed a recent bill passed in the U.S. Senate aimed at lowering drug prices by limiting the number of patents that can be asserted in cases over biosimilars in the Law360 article, “Patent Cap In Drug Pricing Bill Seen As Having Muted Effect.”